Aflac Incorporated (AFL)
- Previous Close
80.26 - Open
80.97 - Bid --
- Ask --
- Day's Range
80.11 - 81.32 - 52 Week Range
64.10 - 86.26 - Volume
2,060,404 - Avg. Volume
2,327,967 - Market Cap (intraday)
46.597B - Beta (5Y Monthly) 0.91
- PE Ratio (TTM)
10.41 - EPS (TTM)
7.78 - Earnings Date May 1, 2024
- Forward Dividend & Yield 2.00 (2.47%)
- Ex-Dividend Date Feb 20, 2024
- 1y Target Est
85.33
Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan. The Aflac U.S. segment provides cancer, accident, short-term disability, critical illness, hospital indemnity, dental, vision, long-term care and disability, and term and whole life insurance products in the United States. It sells its products through sales associates, brokers, independent corporate agencies, individual agencies, and affiliated corporate agencies. Aflac Incorporated was founded in 1955 and is headquartered in Columbus, Georgia.
www.aflac.com12,785
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: AFL
Performance Overview: AFL
Trailing total returns as of 4/18/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: AFL
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: AFL
Valuation Measures
Market Cap
46.60B
Enterprise Value
51.16B
Trailing P/E
10.41
Forward P/E
12.61
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
2.57
Price/Book (mrq)
2.12
Enterprise Value/Revenue
2.72
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
24.91%
Return on Assets (ttm)
2.64%
Return on Equity (ttm)
22.12%
Revenue (ttm)
18.7B
Net Income Avi to Common (ttm)
4.66B
Diluted EPS (ttm)
7.78
Balance Sheet and Cash Flow
Total Cash (mrq)
5.62B
Total Debt/Equity (mrq)
42.24%
Levered Free Cash Flow (ttm)
4.31B
Research Analysis: AFL
Analyst Price Targets
Fair Value
Analyst Recommendations
- Strong Buy
- Buy
- Hold
- Underperform
- Sell
Earnings
Research Reports: AFL
AFL: Lowering target price to $84.00
AFLAC INC has an Investment Rating of HOLD; a target price of $84.000000; an Industry Subrating of Low; a Management Subrating of High; a Safety Subrating of Medium; a Financial Strength Subrating of High; a Growth Subrating of Medium; and a Value Subrating of Low.
RatingNeutralPrice TargetAFL: Lowering target price to $87.00
AFLAC INC has an Investment Rating of HOLD; a target price of $87.000000; an Industry Subrating of Low; a Management Subrating of High; a Safety Subrating of Medium; a Financial Strength Subrating of High; a Growth Subrating of Medium; and a Value Subrating of Low.
RatingNeutralPrice TargetAFL: What does Argus have to say about AFL?
AFLAC INC has an Investment Rating of HOLD; a target price of $89.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Low.
RatingNeutralPrice TargetAFL: What does Argus have to say about AFL?
AFLAC INC has an Investment Rating of HOLD; a target price of $89.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Low.
RatingNeutralPrice Target